222 related articles for article (PubMed ID: 29482875)
1. PEGylated multi-walled carbon nanotubes as versatile vector for tumor-specific intracellular triggered release with enhanced anti-cancer efficiency: Optimization of length and PEGylation degree.
Zhao X; Tian K; Zhou T; Jia X; Li J; Liu P
Colloids Surf B Biointerfaces; 2018 Aug; 168():43-49. PubMed ID: 29482875
[TBL] [Abstract][Full Text] [Related]
2. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.
Ren J; Shen S; Wang D; Xi Z; Guo L; Pang Z; Qian Y; Sun X; Jiang X
Biomaterials; 2012 Apr; 33(11):3324-33. PubMed ID: 22281423
[TBL] [Abstract][Full Text] [Related]
3. The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes.
Mehra NK; Verma AK; Mishra PR; Jain NK
Biomaterials; 2014 May; 35(15):4573-88. PubMed ID: 24612818
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of pH-responsive single-walled carbon nanotube-doxorubicin complexes in cancer cells.
Gu YJ; Cheng J; Jin J; Cheng SH; Wong WT
Int J Nanomedicine; 2011; 6():2889-98. PubMed ID: 22131835
[TBL] [Abstract][Full Text] [Related]
5. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
[TBL] [Abstract][Full Text] [Related]
6. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
Wen S; Liu H; Cai H; Shen M; Shi X
Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
[TBL] [Abstract][Full Text] [Related]
7. Effect of functionalization on drug delivery potential of carbon nanotubes.
Sharma S; Mehra NK; Jain K; Jain NK
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1851-1860. PubMed ID: 26732473
[TBL] [Abstract][Full Text] [Related]
8. Tunable doxorubicin release from polymer-gated multiwalled carbon nanotubes.
Pistone A; Iannazzo D; Ansari S; Milone C; Salamò M; Galvagno S; Cirmi S; Navarra M
Int J Pharm; 2016 Dec; 515(1-2):30-36. PubMed ID: 27720871
[TBL] [Abstract][Full Text] [Related]
9. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes.
Mehra NK; Jain NK
J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734
[TBL] [Abstract][Full Text] [Related]
10. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
[TBL] [Abstract][Full Text] [Related]
11. Design of pH/reduction dual-responsive nanoparticles as drug delivery system for DOX: Modulating controlled release behavior with bimodal drug-loading.
Liu P; Zhang R; Pei M
Colloids Surf B Biointerfaces; 2017 Dec; 160():455-461. PubMed ID: 28985607
[TBL] [Abstract][Full Text] [Related]
12. Polyionic complex of single-walled carbon nanotubes and PEG-grafted-hyperbranched polyethyleneimine (PEG-PEI-SWNT) for an improved doxorubicin loading and delivery: development and in vitro characterization.
Farvadi F; Tamaddon A; Sobhani Z; Abolmaali SS
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):855-863. PubMed ID: 27176858
[TBL] [Abstract][Full Text] [Related]
13. Bio-inspired keratin-based core-crosslinked micelles for pH and reduction dual-responsive triggered DOX delivery.
Zhang H; Liu P
Int J Biol Macromol; 2019 Feb; 123():1150-1156. PubMed ID: 30465843
[TBL] [Abstract][Full Text] [Related]
14. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy.
Hu FQ; Zhang YY; You J; Yuan H; Du YZ
Mol Pharm; 2012 Sep; 9(9):2469-78. PubMed ID: 22827551
[TBL] [Abstract][Full Text] [Related]
15. IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy.
Fu X; Wang X; Zhou S; Zhang Y
Int J Nanomedicine; 2017; 12():3751-3766. PubMed ID: 28553112
[TBL] [Abstract][Full Text] [Related]
16. PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin.
Deng H; Liu J; Zhao X; Zhang Y; Liu J; Xu S; Deng L; Dong A; Zhang J
Biomacromolecules; 2014 Nov; 15(11):4281-92. PubMed ID: 25325531
[TBL] [Abstract][Full Text] [Related]
17. pH Responsive Release of Doxorubicin to the Cancer Cells by Functionalized Multi-Walled Carbon Nanotubes.
Anbarasan B; Babu SV; Elango K; Shriya B; Ramaprabhu S
J Nanosci Nanotechnol; 2015 Jul; 15(7):4799-805. PubMed ID: 26373040
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
[TBL] [Abstract][Full Text] [Related]
19. Leakage-free DOX/PEGylated chitosan micelles fabricated via facile one-step assembly for tumor intracellular pH-triggered release.
Zhao X; Yao Y; Tian K; Zhou T; Jia X; Li J; Liu P
Eur J Pharm Biopharm; 2016 Nov; 108():91-99. PubMed ID: 27594211
[TBL] [Abstract][Full Text] [Related]
20. One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery.
Mehra NK; Jain NK
Mol Pharm; 2015 Feb; 12(2):630-43. PubMed ID: 25517904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
